RE:use of proceeds Increasing the Corporation’s manufacturing capacity for plasma-derived therapeutics = 12 millions
I wonder if a deal is not about to happen regarding the increase in North America? I remember having heard about a few trips by a PLI exec to Winnipeg a few years ago.
Cangene have a plant right there, and they have been bought after by another company.